To date, NCCN has published guidelines for colon, prostate and rectal cancer on the tool, with the aim of publishing all 88 NCCN guidelines on the platform.

The NCCN Guidelines for Patients ® provide expert cancer treatment information to inform and empower patients and caregivers, through support from the NCCN Foundation®.

The new interactive guideline tool represents a major format change for gold-standard NCCN Guidelines.

The National Comprehensive Cancer Network (NCCN)—an alliance of leading cancer centers—announces a new, interactive digital delivery format for the NCCN Clinical Practice Guidelines in ...

NCCN Clinical Practice Guidelines in Oncology Prostate Cancer The National Comprehensive Cancer Network issues updated guidelines for the diagnosis and management of prostate cancer.

Geneoscopy's ColoSense has been included in the latest update to the National Comprehensive Cancer Network Guidelines for CRC screening.

NCCN Guidelines® recommend FES PET for systemic staging in certain patients with invasive lobular cancer (ILC), which could facilitate greater diagnostic accuracy, earlier interventions, better ...

This inclusion in the NCCN Guidelines recognizes PEMGARDA as a potential option for PrEP against COVID-19 in patients with B-cell malignancies. Immunocompromised patients may not mount an adequate ...

Danyelza is now a recommended treatment in NCCN guidelines for relapsed or refractory high-risk neuroblastoma, a type of brain cancer.

In its updated guidelines for colon cancer 1 and for rectal cancer 2, NCCN now includes ctDNA as a high risk factor for recurrence in the adjuvant setting, recognizing its prognostic value.

Puma Biotechnology (PBYI) announced that the National Comprehensive Cancer Network, or NCCN, Clinical Practice Guidelines in Oncology for Cervical Cancer were updated to include an addition ...